Production rate determines plasma concentration of large high density lipoprotein in non-human primates.
Large LpAI HDL particles, containing only apoA-I without apoA-II, are reported to be the major anti-atherogenic portion of HDL and to be increased in individuals with low risk for coronary heart disease. To determine whether the plasma concentration of large LpAI is modulated by the rate of production or catabolism of apolipoprotein A-I (apoA-I) in large LpAI, kinetic studies of large LpAI were performed in African green monkeys consuming an atherogenic diet with either high plasma HDL concentration (120 +/- 36 mg/dl, mean +/- SD, n = 3) or low plasma HDL concentration (40 +/- 13 mg/dl, n = 3). Large LpAI was isolated, without ultracentrifugation, by immunoaffinity and gel filtration and radiolabeled. After injection, the specific activity of apoA-I in large HDL, consisting of both LpAI and LpAI:AII particles, was followed. A multicompartmental model was developed for the kinetics of apoA-I in large HDL, which indicated that a portion of large HDL is distributed to a sequestered pool, outside the circulating plasma, and reenters circulating plasma approximately 3 h after injection. There was no conversion of large LpAI to smaller HDL particles or transfer of radiolabeled apoA-I to smaller HDL particles. Although the mean fractional catabolic rate was not different comparing the high and low HDL group, the mean production rate of apoA-I in large HDL was 4-fold greater in the high HDL group compared with the low HDL group. These data support the hypothesis that the plasma concentration of large HDL is controlled primarily by the rate of production of apoA-I in large HDL.
Colvin
P
P
Department of Internal Medicine, University of Maryland School of Medicine and the Baltimore Veterans Affairs Medical Center, 21201, USA.
Moriguchi
E
E
Barrett
H
H
Parks
J
J
Rudel
L
L
D000818:Animals; D016632:Apolipoprotein A-I / Q000032:analysis / Q000096:biosynthesis*; D002522:Chlorocebus aethiops; D002784:Cholesterol / Q000097:blood; D007700:Kinetics; D008075:Lipoproteins, HDL / Q000096:biosynthesis* / Q000097:blood*; D008297:Male; D010316:Particle Size; D012307:Risk Factors
D016632:Apolipoprotein A-I; D008075:Lipoproteins, HDL; D002784:Cholesterol